State Street Corp's Strategic Acquisition in Krystal Biotech Inc
Stifel Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $220
Stifel Nicolaus Remains a Buy on Krystal Biotech (KRYS)
Krystal Biotech, Inc. (KRYS): Promising Pipeline or Risky Gamble?
Krystal Biotech Insider Sold Shares Worth $9,888,276, According to a Recent SEC Filing
Krystal Biotech(KRYS.US) 10% Shareholder Sells US$9.89 Million in Common Stock
$Krystal Biotech(KRYS.US)$ 10% Shareholder Krishnan Krish S sold 50,000 shares of common stock on Sep 12, 2024 at an average price of $197.7655 for a total value of $9.89 million. This transaction